6/28/24- I am about to start calquence. I would appreciate your words of encouragement and advice. Follow-up mLeft upper pole 1.8 cm hypoenhancing solid renal lesion concerning for renal cell carcinoma, papillary subtype. Less likely differential of lymphomatous lesion.
Innumerable additional small foci of restricted diffusion scattered diffusely in both kidneys, most likely representing lymphomatous involvement of kidneys. Majority of the lesions are not well discernable on CT.
Enlarged abdominal lymph nodes reflecting known lymphoma, slightly decreased in size compared with prior CT 6/7/2024.
MRI ABDOMEN WITH AND WITHOUT IV CONTRAST
CLINICAL INDICATION: Renal lesions. History of small lymphocytic lymphoma.
TECHNIQUE: Multiplanar T1-weighted, T2-weighted, and diffusion-weighted sequences were obtained of the abdomen, including dynamic post-contrast T1-weighted sequences.
CONTRAST: 8.5 ml of GADOBUTROL 10 MMOL/10 ML (1 MMOL/ML) INTRAVENOUS SOLUTION was administered (the balance of single use vial(s) has/have been discarded).
COMPARISON: CT from 06/07/2024
FINDINGS:
01. LIVER: Normal morphology and signal intensity. No suspicious lesion. Multiple simple and thin-septated hepatic cysts measuring up to 3.0 cm.
02. SPLEEN: Normal size. Few subcentimeter cysts.
03. PANCREAS: Normal.
04. GALLBLADDER/BILIARY TREE: No biliary duct dilatation. Normal gallbladder.
05. ADRENALS: Normal.
06. KIDNEYS: Symmetric renal enhancement. No hydronephrosis.
Left upper pole 1.8 x 1.6 cm T2 hypointense round lesion (series 4, image 17) associated diffusion restriction and low-level heterogeneous internal enhancement (series 14, image 36). This lesion is suspicious for primary renal neoplasm with less likely differential of lymphomatous lesion.
Innumerable additional small foci of restricted diffusion scattered diffusely in both kidneys (series 11 image 89-103) with low level enhancement and nearly isointense on precontrast T1 or T2 images, different from the left upper pole lesion, most likely representing lymphomatous involvement of kidneys. These are mostly subcentimeter in size, and the largest measuring 1.5 cm in the right upper pole (series 11 image 97), corresponding to the 1.0 x 0.7 cm lesion seen on CT. Majority of lesions are not well discernable on CT.
1.6 cm left upper pole simple cyst (series 10 image 43).
07. LYMPHADENOPATHY/RETROPERITONEUM: Multiple enlarged abdominal nodes including retroperitoneal and mesenteric lymph nodes, compatible with known lymphoma, as seen on recent CT, with reference lesions as follows:
-Anterior left para-aortic lymph node, 4.6 x 2.0 cm (series 11, image 96), previously 5.1 x 2.2 cm.
-Left para-aortic lymph node, 4.8 x 3.1 cm (series 11, image 104), previously 5.4 x 3.3 cm.
-Porta hepatis, 3.6 x 2.3 cm (series 11, image 88), previously 3.5 x 2.1 cm
-Mesenteric lymph node conglomerate, 7.2 x 2.9 cm (series 11, image 101), previously 7.0 x 3.8 cm
08. BOWEL: No bowel obstruction.
09. PERITONEUM/ABDOMINAL WALL: No ascites.
10. VASCULATURE: Normal caliber abdominal aorta. Patent portomesenteric vasculature. Encased bilateral renal arteries by retroperitoneal lymphadenopathy, which remain patent. Patent bilateral renal veins.
11. SKELETAL: No aggressive lesions.
12. LUNG BASES: No nodule or pleural effusion.